Related Party Transactions

9 Months Ended

Sep. 30, 2022

Related Party Transactions

Related Party Transactions

17. Related Party Transactions

As of September 30, 2022, Vifor International owned 7,396,770, or 13.8%, of the Company’s common stock. Both Vifor and Vifor International are considered related parties as of September 30, 2022 and December 31, 2021 (see Note 11, Collaboration and Licensing Agreements).

As of September 30, 2022, amounts due from Vifor of $9,623 relating to the Company’s profit-share revenue from sales of KORSUVA injection in the U.S. by Vifor and its commercial supply of KORSUVA injection to Vifor were included within Accounts receivable, net – related party on the Company’s Condensed Balance Sheet.

The Company’s profit-share revenue of $7,443 and $15,446 from sales of KORSUVA injection in the U.S. by Vifor were included within Collaborative revenue on the Company’s Condensed Statements of Comprehensive Loss for the three and nine months ended September 30, 2022, respectively.

Sales of KORSUVA injection to Vifor of $3,370 and $8,160 were included within Commercial supply revenue on the Company’s Condensed Statements of Comprehensive Loss for the three and nine months ended September 30, 2022, respectively.